High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

Detalles Bibliográficos
Autores principales: McNamara, Lucy A., Topaz, Nadav, Wang, Xin, Hariri, Susan, Fox, LeAnne, MacNeil, Jessica R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2017
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687588/
https://www.ncbi.nlm.nih.gov/pubmed/28704351
http://dx.doi.org/10.15585/mmwr.mm6627e1
_version_ 1783278984935505920
author McNamara, Lucy A.
Topaz, Nadav
Wang, Xin
Hariri, Susan
Fox, LeAnne
MacNeil, Jessica R.
author_facet McNamara, Lucy A.
Topaz, Nadav
Wang, Xin
Hariri, Susan
Fox, LeAnne
MacNeil, Jessica R.
author_sort McNamara, Lucy A.
collection PubMed
description
format Online
Article
Text
id pubmed-5687588
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-56875882018-01-17 High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine McNamara, Lucy A. Topaz, Nadav Wang, Xin Hariri, Susan Fox, LeAnne MacNeil, Jessica R. MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2017-07-14 /pmc/articles/PMC5687588/ /pubmed/28704351 http://dx.doi.org/10.15585/mmwr.mm6627e1 Text en https://creativecommons.org/licenses/by/3.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
spellingShingle Full Report
McNamara, Lucy A.
Topaz, Nadav
Wang, Xin
Hariri, Susan
Fox, LeAnne
MacNeil, Jessica R.
High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
title High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
title_full High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
title_fullStr High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
title_full_unstemmed High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
title_short High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
title_sort high risk for invasive meningococcal disease among patients receiving eculizumab (soliris) despite receipt of meningococcal vaccine
topic Full Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687588/
https://www.ncbi.nlm.nih.gov/pubmed/28704351
http://dx.doi.org/10.15585/mmwr.mm6627e1
work_keys_str_mv AT mcnamaralucya highriskforinvasivemeningococcaldiseaseamongpatientsreceivingeculizumabsolirisdespitereceiptofmeningococcalvaccine
AT topaznadav highriskforinvasivemeningococcaldiseaseamongpatientsreceivingeculizumabsolirisdespitereceiptofmeningococcalvaccine
AT wangxin highriskforinvasivemeningococcaldiseaseamongpatientsreceivingeculizumabsolirisdespitereceiptofmeningococcalvaccine
AT haririsusan highriskforinvasivemeningococcaldiseaseamongpatientsreceivingeculizumabsolirisdespitereceiptofmeningococcalvaccine
AT foxleanne highriskforinvasivemeningococcaldiseaseamongpatientsreceivingeculizumabsolirisdespitereceiptofmeningococcalvaccine
AT macneiljessicar highriskforinvasivemeningococcaldiseaseamongpatientsreceivingeculizumabsolirisdespitereceiptofmeningococcalvaccine

Ejemplares similares